Terapia Génica del Cáncer
TGC
Universitat Autònoma de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat Autònoma de Barcelona (13)
2024
-
Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration
Nature Communications, Vol. 15, Núm. 1
2023
-
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Nature Communications, Vol. 14, Núm. 1
-
Protective ileostomy creation after anterior resection of the rectum: Shared decision-making or still subjective?
Colorectal Disease, Vol. 25, Núm. 4, pp. 647-659
2021
-
A CT-based radiomics signature is associated with response to immune checkpoint inhibitors in advanced solid tumors
Radiology, Vol. 299, Núm. 1, pp. 109-119
-
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
European Journal of Cancer, Vol. 155, pp. 168-178
2020
-
Capturing hyperprogressive disease with immune-checkpoint inhibitors using RECIST 1.1 criteria
Clinical Cancer Research, Vol. 26, Núm. 8, pp. 1846-1855
-
Identification of expression profiles defining distinct prognostic subsets of radioactive-iodine refractory differentiated thyroid cancer from the DECISION trial
Molecular Cancer Therapeutics, Vol. 19, Núm. 1, pp. 312-317
2019
-
Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials
Expert Opinion on Investigational Drugs, Vol. 28, Núm. 5, pp. 463-471
2018
-
Early evolutionary divergence between papillary and anaplastic thyroid cancers
Annals of Oncology, Vol. 29, Núm. 6, pp. 1454-1460
-
Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer
Expert Opinion on Pharmacotherapy, Vol. 19, Núm. 6, pp. 623-629
-
Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)
International Journal of Colorectal Disease, Vol. 33, Núm. 2, pp. 241-249
-
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain
Psycho-Oncology, Vol. 27, Núm. 6, pp. 1530-1537
-
The safety of ramucirumab for the treatment of colorectal cancer
Expert Opinion on Drug Safety, Vol. 17, Núm. 9, pp. 945-951